Ionis Pharmaceuticals
$67.969876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$67.96
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
+$0.11 (0.16%) Today
$0.00 (0.00%) As of 4:27 PM EDT after-hours
Why Robinhood?
You can buy or sell IONS and other stocks, options, ETFs, and crypto commission-free!
About IONS
Ionis Pharmaceuticals, Inc. engages in the development and commercialization of human therapeutic drugs using antisense technology. It operates through the Ionis Core and Akcea Therapeutics segments. Read More The Ionis Core segment exploits a novel drug discovery platform to generate a pipeline of drugs. The Akcea Therapeutics segment develops and commercializes drugs for cardiometabolic diseases. The company was founded by Stanley T. Crooke, David J. Ecker, Christopher K. Mirabelli and Brett P. Monia in 1989 and is headquartered in Carlsbad, CA.
Employees
737
Headquarters
Carlsbad, California
Founded
1989
Market Cap
9.55B
Price-Earnings Ratio
24.40
Dividend Yield
0.00
Average Volume
1.00M
High Today
$69.27
Low Today
$67.44
Open Price
$67.92
Volume
1.10M
52 Week High
$86.58
52 Week Low
$43.27
Collections
IONS News
Price Paid on Robinhood
26% Higher
Right Now
52 Week Low
$39.07
Average Price Paid
$53.73
52 Week High
$86.58
Analyst Ratings
24%
of 17 ratings
Buy
24%
Hold
59%
Sell
18%
IONS Earnings
-$0.27
$0.03
$0.32
$0.62
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Q3 2019
Estimated
—
Actual
Expected Nov 5, Pre-Market